IRIX (Iridex Corp) Stock Analysis - Hedge Fund Holdings
Iridex Corp (IRIX) is a publicly traded Healthcare sector company. As of May 20, 2026, IRIX trades at $1.07 with a market cap of $17.66M and a P/E ratio of 0.00. IRIX moved +3.45% today. Year to date, IRIX is -10.26%; over the trailing twelve months it is -1.87%. Its 52-week range spans $0.78 to $1.95. Analyst consensus is buy with an average price target of $2.75. Rallies surfaces IRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns IRIX stock?
Hedge funds tracked by Rallies that own IRIX include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Iridex Corp.
IRIX Key Metrics
Key financial metrics for IRIX
Metric
Value
Price
$1.07
Market Cap
$17.66M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$1.95
52-Week Low
$0.78
Volume
127.58K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Top Hedge Funds Holding IRIX
Renaissance Technologies holds 381.16K shares of IRIX, changed -4.08% as of Dec 31, 2024.
Citadel Advisors holds 67.65K shares of IRIX, changed +34.56% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own IRIX include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Iridex Corp.
Does Rallies show 13F holders for IRIX?
Yes. Rallies tracks hedge fund and 13F ownership data for IRIX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is IRIX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IRIX. It does not provide personalized investment advice.
